Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Deplanque

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Journal of Clinical Psychopharmacology|April 26, 2020
An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover StudyAnna Chan Kwong, Catherine Cassé-Perrot, Marie-Claude Costes-Salon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 18, 2022
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccinationEnagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective StudyOdile Launay, Vered Abitbol, Anne Krivine, et al.
Nature Medicine|January 8, 2025
Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trialCaroline Moreau, Pascal Odou, Julien Labreuche, et al.
Communications Medicine|January 18, 2025
Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variantsOdile Launay, Rachna Gupta, Tifany Machabert, et al.
Gastroenterology|December 4, 2015
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative ColitisFranck Carbonnel, Jean Frédéric Colombel, Jérome Filippi, et al.
The New England Journal of Medicine|June 29, 2022
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster VaccineOdile Launay, Marine Cachanado, Liem B Luong Nguyen, et al.
Scientific Reports|November 27, 2022
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsChristine Durier, Laetitia Ninove, Maeva Lefebvre, et al.
Ophthalmology|June 21, 2016
Clinical Characteristics and Risk Factors of Extensive Macular Atrophy with Pseudodrusen: The EMAP Case-Control National Clinical TrialAymeric Douillard, Marie-Christine Picot, Cécile Delcourt, et al.
Scientific Reports|May 3, 2018
Dietary, environmental, and genetic risk factors of Extensive Macular Atrophy with Pseudodrusen, a severe bilateral macular atrophy of middle-aged patientsAymeric Douillard, Marie-Christine Picot, Cécile Delcourt, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Journal of Clinical Psychopharmacology|April 26, 2020
An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover StudyAnna Chan Kwong, Catherine Cassé-Perrot, Marie-Claude Costes-Salon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 18, 2022
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccinationEnagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective StudyOdile Launay, Vered Abitbol, Anne Krivine, et al.
Nature Medicine|January 8, 2025
Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trialCaroline Moreau, Pascal Odou, Julien Labreuche, et al.
Communications Medicine|January 18, 2025
Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variantsOdile Launay, Rachna Gupta, Tifany Machabert, et al.
Gastroenterology|December 4, 2015
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative ColitisFranck Carbonnel, Jean Frédéric Colombel, Jérome Filippi, et al.
The New England Journal of Medicine|June 29, 2022
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster VaccineOdile Launay, Marine Cachanado, Liem B Luong Nguyen, et al.
Scientific Reports|November 27, 2022
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsChristine Durier, Laetitia Ninove, Maeva Lefebvre, et al.
Ophthalmology|June 21, 2016
Clinical Characteristics and Risk Factors of Extensive Macular Atrophy with Pseudodrusen: The EMAP Case-Control National Clinical TrialAymeric Douillard, Marie-Christine Picot, Cécile Delcourt, et al.
Scientific Reports|May 3, 2018
Dietary, environmental, and genetic risk factors of Extensive Macular Atrophy with Pseudodrusen, a severe bilateral macular atrophy of middle-aged patientsAymeric Douillard, Marie-Christine Picot, Cécile Delcourt, et al.
Pageof 11